Why the study?
Clinical use of fNIRS-derived features has suffered low sensitivity and specificity due to signal contamination from background systemic physiological fluctuations.
Does an fNIRS-derived neurocognitive ratio (NCR) improve the classification accuracy of healthy individuals versus patients with neuropsychiatric diseases?
Population
Healthy controls and patients with migraine, obsessive compulsive disorder, and schizophrenia
Comparison
fNIRS-derived biomarker based on global efficiency during a computerized Stroop task
Authors
Loading...
May refine fNIRS cognition biomarkers; leaves open prospective validation before clinical use.
Does an fNIRS-derived neurocognitive ratio (NCR) improve the classification accuracy of healthy individuals versus patients with neuropsychiatric diseases?
The fNIRS-derived neurocognitive ratio (NCR) demonstrates high sensitivity and specificity as a potential biomarker for classifying neuropsychiatric diseases.
Ata Akın (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: